Penumbra IncPEN
Price$318.00Intrinsic value$345.579% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $345.57median of 6 methods · middle span $250-$501based on filings through 30 Jun 2026
Market Price $318.00Price as of 1 Oct 2026
Margin of Safety +8.7%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 29.4% (near-term consensus, capped) · years 2–5: 20.3%/yr (balance of the path).22.1% per year
Years 6–10: glide to demonstrated growth own history 40.3%, capped at 20%
Per-year rates
Yr 620.2%Yr 720.2%Yr 820.1%Yr 920.1%Yr 1020.0%
20.3% → 20.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1118.3%Yr 1216.6%Yr 1314.9%Yr 1413.2%Yr 1511.5%Yr 169.8%Yr 178.1%Yr 186.4%Yr 194.7%Yr 203.0%
20.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (6/7y) (limited history)40.3%
Discount rate (cost of equity) 8.5%
Volatility vs market (adjusted beta)0.80

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetPenumbra IncPENHealth Care
Valuation
P/E78.1×
P/S8.4×
P/B8.3×
EV / Revenue8.2×
EV / EBITDA54.8×
Profitability
Gross margin67.1%
Operating margin13.5%
Net margin10.7%
FCF margin14.3%
Returns
ROE10.5%
ROA8.1%
ROIC11.9%
Growth
Revenue growth (YoY)26.0%
5-yr fwd EPS growth22.1%
Financial strength
Debt / Equity0.02×
Current ratio5.75×
Altman Z-Score19.0
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.